期刊文献+

聚乙二醇干扰素治疗慢性丙型肝炎疗效观察 被引量:2

原文传递
导出
出处 《中国临床研究》 CAS 2010年第4期318-318,共1页 Chinese Journal of Clinical Research
  • 相关文献

参考文献6

  • 1Manns MP, McHutchisou JG, Gordon SC, et al. Peginterferon alfa-2b plus fibavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial[J].Lancet,2001, 358 (9286) :958 - 965.
  • 2Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[J].N Engl J Med, 2002,347 ( 13 ) :975 - 982.
  • 3中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 4Luxon BA,Grace M,Brassar D,et al. Pegylated interferons for the treatment of chronic hepatic C infection[J]. Clin Ther,2002,24(9) :1363 - 1383.
  • 5马慧,王豪.长效干扰素:聚乙二醇干扰素研究进展[J].中华肝脏病杂志,2002,10(1):78-79. 被引量:48
  • 6袁孝蓉,安富荣.聚乙二醇化干扰素α-2a治疗病毒性肝炎新进展[J].中国药房,2006,17(5):387-389. 被引量:8

二级参考文献25

  • 1Modi MW,Fulton JS,Buckmann DK,et al.Clearance of pegylated(40kD) interferon alfa-2a (PEGASYSTM)is primarily hepatic[J].Hepatology,2000,32(4):371a.
  • 2Reddy KR,Wright TL,Pockros PJ,et al.Efficacy and safety of pegylated(40kD) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C[J].Hepatology,2001,33(2):433.
  • 3Zeuzem S,Feinman SV,Rasenack J,et al.Peginterferon alfa-2a in patients with chronic hepatitis C[J].N Engl J Med,2000,343(23):1 666.
  • 4Fried MW,Shiffman ML,Reddy KR,et al.Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[J].N Engl J Med,2002,347(13):975.
  • 5Hadziyannis SJ,Sette HJ,Morgan TK,et al.Peginterferon alpha-2a and ribavirin combination therapy in chronic hepatitis C:a randomized study of treatment duration and ribavirin dose[J].Ann Intern Med,2004,140(5):346.
  • 6Cooksley WG,Piratvisuth T,Lee SD,et al.Peginterferon alfa-2a(40kD):an advance in the treatment of HBeAg-positive chronic hepatitis B[J].J Viral Hepat,2003,10(4):298.
  • 7Lau GK,Piratvisuth T,Luo KX,et al.Peginterferon alfa-2a,lamivudine,and the combination for HBeAg -positive chronic hepatitis B[J].N Engl J Med,2005,352(26):2 682.
  • 8Marcellin P,Lau GK,Bonino F,et al.Peginterferon alfa-2a alone,lamivudine alone,and the two in combination in patients with HBeAg-negative chronic hepatitis B[J].N Engl J Med,2004,351(12):1 206.
  • 9Torriani FJ,Rodriguez-Torres M,Rockstroh JK,et al.Peginteron alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients[J].N Engl J Med,2004,351(5):438.
  • 10Kozlowski A,Charles SA,Harris MJ.Development of pegylated interferons for the treatment of chromic hepatitis C[J].Bio Drugs,2001,15(7):419.

共引文献14056

同被引文献14

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部